Pricing Log in Create free account

Aldeyra Therapeutics, Inc. (ALDX) vs LianBio Sponsored ADR (LIANY)

Aldeyra Therapeutics, Inc. and LianBio Sponsored ADR are both Biotechnology companies. Aldeyra Therapeutics, Inc. and LianBio Sponsored ADR are of similar size ($37.2M and $34.2M). Aldeyra Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 9 metrics below, LianBio Sponsored ADR leads on 7 and Aldeyra Therapeutics, Inc. on 2.

Valuation

Metric ALDX LIANY Biotechnology median
P/E n/m 0.01 10.60
P/S n/m n/m 9.40
P/B 1.02 0.01 2.13
Price to free cash flow n/m 0.02 25.18
EV/EBITDA n/m 5.73 0.66
EV/Sales n/m n/m 9.02
Earnings yield (60.94%) 7,216.75% (32.88%)
Free cash flow yield (57.10%) 5,994.86% (23.13%)

Profitability

Metric ALDX LIANY Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.48%) 70.96% (51.96%)
Return on assets (34.80%) 66.19% (46.06%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric ALDX LIANY Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 40.43% 75.44% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALDX LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.91 17.03 4.97
Net debt to EBITDA 1.52 7.41 1.01

Dividend

Metric ALDX LIANY Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric ALDX LIANY Biotechnology median
Market cap 37.16m 34.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack